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Abstract
Background: Although cardiac fibroma has been regarded as benign tumor, it presents various symptoms and
may lead to death. Unfortunately, only a few studies have reported the epidemiology, embryology, and
histopathology of the tumor, and the factors predicting poorer outcome are still obscured.
Methods: In July 2011 we searched for English and Japanese cases of cardiac fibroma using the PubMed and
IgakuChuoZasshi databases. We then extracted and sampled raw data from the selected publications in accordance
with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) style as much as was
possible.
Results: Details of a total of 178 patients with cardiac fibroma were retrieved. The mean age was 11.4 years
(median: 2.8 years). Tumor sizes ranged from 8.0 to 150.0 mm (mean 53.1 mm). The left ventricle was found to be
the most common site associated with the tumor at a rate of 57.3%, followed by the right ventricle, and
interventricular septum. The highest mortality was found in patients with septal involvement (58.6%). In all, 111
patients survived among the 160 patients with a recorded outcome. A younger age of the patient at the time of
diagnosis was associated with a decreased survival rate. In addition, a significant positive association was found
between ages for patients younger than 17 years of age and the diameter of the tumor at the time of diagnosis
(r = 0.341, P = 0.006).
Conclusions: Both the younger age of patients at the time of diagnosis and septal involvement can be regarded
as factors significantly indicating a poor prognosis. Furthermore, our statistical analyses support the following
hypotheses. First, the high ratio of tumor-to-heart size may generate low cardiac output and therefore lead to poor
outcome. Second, the ratio of the sites where cardiac fibroma occurred corresponds with the ratio of the muscular
weight of the cardiac chamber. Third, cardiac fibroma involving the interventricular septum more frequently
induces conduction system disease.
Background
Primary cardiac tumors are extremely rare, with a
reported incidence ranging from 0.0017 to 0.019% [1].
Of such tumors, about 75% are benign nature [2,3]. Car-
diac fibroma is the second most common primary car-
diac tumor in infants and young children after
rhabdomyoma [4,5]. Although cardiac fibroma is a
benign and solitary tumor [6] composed of fibroblasts
and collagen [7,8], it is clinically important as it may
present with symptoms such as inflow and outflow
obstruction, conduction system disease, and sudden
death [9,10]. In contrast to cardiac rhabdomyoma, car-
diac fibroma rarely regresses spontaneously [11] and
surgical removal in a symptomatic case should be con-
sidered [12,13]. Unfortunately, only a few studies have
reported the epidemiology, embryology, and histopathol-
ogy of the cardiac fibroma. Thus, we searched literature
databases in July 2011 and selected publications related
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predicting poor outcome.
Methods
Data collection
In July 2011 we searched English and Japanese lan-
guages case reports of cardiac fibroma using PubMed
http://www.ncbi.nlm.nih.gov/pubmed/ and IgakuChuo-
Zasshi http://www.jamas.or.jp/ databases by conducting
as e a r c hf o r‘fibroma’ with no time limitations. In the
PubMed search, ‘case report’ and ‘English’ options were
used as an additional tool, and the PubMed system
automatically conducted ‘Medical Subject Headings’ or
‘All Fields’ searches for ‘fibroma’.
In contrast, for the IgakuChuoZasshi search the ‘shor-
eihoukoku’ (Japanese word meaning case report) option
was used as an additional tool. We then reviewed the
searched abstracts of publications selected from the
databases to determine the cumulative number of
reported cardiac fibroma cases. Additionally, we
reviewed the references of the selected publications in
order to find and include publications that were not
recorded in the databases.
We then extracted and sampled the raw data from the
selected publications and our autopsy case in relation to
factors such as age, gender, clinical symptoms, surgical
intervention, outcome, site of the tumor, and maximum
diameter of the tumor. In the present study, data collec-
tion was performed in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-Ana-
lyses (PRISMA) style [15] as much as was possible.
Statistical analyses
Comparison of survival
To clarify poor prognostic factors in patients with car-
diac fibroma, we compared the patient age and maxi-
mum diameter of the tumor at the time of diagnosis
between patients that survived and those that did not
survive. The analyses were performed using the Mann-
Whitney U test.
Comparison of gender
To determine whether there were gender differences in
patients with cardiac fibroma, we compared the patient
age and maximum diameter of the tumor at the time of
diagnosis between males and females with cardiac
fibroma. The analyses were performed using the Mann-
Whitney U test.
Correlation between patient age and tumor size
We used the Spearman correlation coefficient to know
the correlation between the patient age and maximum
diameter of the tumor at the time of diagnosis. Since it
has been reported [16] that the growth of the heart is
usually completed at 17 to 20 years of age, we also cal-
culated the Spearman correlation coefficient between
the patient age and maximum diameter of the tumor at
the time of diagnosis in patient groups under 17 years
of age and those over 17 years of age, independently.
Relative size of tumor of cardiac fibroma
Since younger individuals have smaller hearts than older
individuals [17], analyses using mere tumor size may be
insufficient to assess the effect of tumor size on survival,
and a consideration of physiological cardiac growth
should be required. Therefore, we calculated the tumor-
to-heart size ratio of patients by dividing the maximum
diameter of the tumor (DT) by the physiological cardiac
weight (CW) [17], and created a scatter plot of DT/CW.
We then used the Spearman rank correlation coefficient
to confirm the correlation between DT/CW and the
patient age at the time of diagnosis. Additionally, to
confirm the correlation between DT/CW and patient
outcome, we used the Mann-Whitney U test to compare
DT/CW between patients that survived and those that
did not survive.
Correlation between tumor occurrence and cardiac
chamber weight
To confirm the correlation between tumor occurrence
and cardiac chamber weight, we compared the ratio of
the number of tumor sites and the muscular weight of
the cardiac chamber using the c
2 test. Muscular weight
was determined using examples of previous publication
reported by Sandstede et al. [18]. To determine the
weight of the interventricular septum in the present
study, we divided the left ventricle into four zones com-
prising anterior wall, lateral wall, posterior wall, and
interventricular septum.
Correlation between site of cardiac fibroma and outcome
Since a previous report indicated that patients with
interventricular septal cardiac fibroma have a poorer
outcome [19], we used the c
2 test to compare mortality
between patients whose condition involving or not
involving the interventricular septum. We then com-
pared DT/CW between these groups of patients using a
Mann-Whitney U test, and compared the incidence of
arrhythmia between these groups of patients using the
c
2 test.
Differences were considered significant at P <0 . 0 5i n
all statistical analyses.
Results
Data collection
We retrieved 4,787 English and 1,901 Japanese (total
6,688) publications by conducting a search for ‘fibroma’
using PubMed and IgakuChuoZasshi databases. Of these
publications, 99 English and 6 Japanese manuscripts
were selected as describing representative cases of car-
diac fibroma, with the remaining 6,583 publications
being excluded. We then reviewed the references of
these 105 selected publications and included another 16
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reports concerning 177 patients with cardiac fibroma.
We added our autopsy patient to this list and thus
extracted data from a total of 178 patients.
The patient age at the time of diagnosis ranged from 0
(including prenatal cases) to 83 years (n = 160, 18 not
reported, mean ± SD: 11.4 ± 18.5) and the median age at
the time of diagnosis was 2.8 years. A total of 65 patients,
or 40.6% of the total, were in the group comprising
patients less than 1 year of age, and 18 patients, or 11.3%
of the total, were in the group comprising prebirth or neo-
natal cases. The gender ratio was 92:78 male to female
(n = 170, gender not reported in 8 cases). The maximum
d i a m e t e ro ft h et u m o ra tt h et i m eo fd i a g n o s i sr a n g e d
from 8.0 to 140.0 mm (n = 92, 86 not reported, mean ±
SD: 52.9 ± 23.9 mm). The left ventricle (98/171, 57.3%)
was found as the commonest site of the tumor, followed
by the right ventricle (47/171, 27.5%), interventricular sep-
tum (29/171, 17.0%), right atrium (9/171, 5.3%), and left
atrium (3/171, 1.8%). In all, 18 patients had cardiac
fibroma that involved 2 or 3 continuous sites of the myo-
cardium. The outcome of 160 patients was described: 111
patients survived and 49 died. Surgical intervention for the
cardiac fibroma was undertaken in 119 of the 178 cases, of
which 87 patients survived and 22 died (10 not reported).
Statistical analysis
Comparison of survival
We confirmed that 111 patients with cardiac fibroma
survived and 49 patients died.
Of these 160 patients, the age of 142 patients was docu-
mented. The mean age ± SD of the group that survived
was 13.5 ± 18.4 years (n = 93), while for the group that
did not survive it was 5.8 ± 16.2 years (n = 49). The
group that did not survive was significantly younger than
the group that survived (Mann-Whitney U test: P <
0.001). Of the 160 cases, 82 included reports of the maxi-
mum diameter of the tumor at the time of diagnosis. The
mean ± SD tumor diameter of the group that survived
was 53.3 ± 25.0 mm (n = 62), while that of the group that
did not survive was 48.7 ± 19.4 mm (n = 20). No signifi-
cant difference was found between these groups in regard
to tumor diameter (Mann-Whitney U test: P = 0.810).
These data are summarized in Table 1
Comparison of gender
The mean ± SD age of males and females at the time of
diagnosis was 10.8 ± 18.4 years (n = 84) and 12.2 ± 18.6
years (n = 68), respectively (gender not reported for 26
patients). No significant difference was found for patient
age between these groups (Mann-Whitney U test: P =
0.529). The mean ± SD tumor diameter of males and
females was 51.6 ± 23.5 mm (n = 49) and 54.7 ± 24.1
mm (n = 43), respectively (size not reported for 85
patients). No significant difference was found in tumor
diameter between these groups (Mann-Whitney U test:
P = 0.562). These data are summarized in Table 1.
A total of 23 of the 84 (27.4%) male patients and 20 of
the 67 (29.9%) female patients died (outcome not
reported for 27 patients). No significant difference was
found in mortality between these groups (c
2, P = 0.738).
Correlation between patient age and tumor size
Our literature survey revealed that 18 of the 178
patients with cardiac fibroma (11.3%) were diagnosed
during the prenatal or neonatal period, and that this
tumor had a certain size regardless of patient age. Cal-
culation of the Spearman correlation coefficient using
the patient age and maximum diameter of the tumor at
the time of diagnosis (n = 92, 85 not reported) showed
a significant positive association between these factors
(r = 0.338, P = 0.001).
The Spearman correlation coefficient was calculated
between ages for patients under 17 years of age (n = 64)
and for those over 17 years of age (n = 28) and tumor
diameter. Results showed a significant positive correla-
tion between patient age and tumor diameter (r = 0.341,
P = 0.006) for patients under 17 years of age, while
there was no significant correlation between these fac-
tors for patients over 17 years of age (r = -0.080,
P = 0.676).
Relative size of tumor of cardiac fibroma
The scatter plot of DT/CW and patient age at the time
of diagnosis (Figure 1) showed a significant negative
association (Spearman’s rank correlation coefficient, r =
-0.863, P < 0.001). Furthermore, a significant difference
was found in DT/CW between patients that survived
(n = 62, mean ± SD: 0.67 ± 0.57 mm/g) and those that
did not survive (n = 20, mean ± SD: 1.16 ± 0.75 mm/g)
(Mann-Whitney U test: P = 0.008).
Correlation between site of tumor occurrence and cardiac
chamber weight
T h ep r e s e n ts t u d yf o u n dt h a tt h el e f tv e n t r i c l ew a st h e
most common site associated with cardiac fibroma
(98/171, 57.3%), followed by the right ventricle (47/171,
27.5%) and interventricular septum (29/171, 17.0%). We
Table 1 Differences between gender and patient outcome
Male Female P value Survival Dead P value
Age, years 10.8 ± 18.4 (n = 84) 12.2 ± 18.6 (n = 68) 0.529 13.5 ± 18.4 (n = 93) 5.8 ± 16.2 (n = 49) < 0.001
Diameter, mm 51.6 ± 23.5 (n = 49) 54.7 ± 24.1 (n = 43) 0.562 53.3 ± 25.0 (n = 62) 48.7 ± 19.4 (n = 20) 0.810
Age is age at time of diagnosis, diameter is the maximum diameter at time of diagnosis. Values are mean ± SD, P values by Mann-Whitney test.
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tumor occurrence and cardiac chamber weight, and no
significant difference was found in ratio between the
number of tumor sites (left ventricle: right ventricle:
interventricular septum, 98:47:29) and muscular weight
of the cardiac chamber (left ventricle free wall: right
ventricle: interventricular septum, 99:45:33) (c
2 test,
P = 0.869).
Correlation between site of cardiac fibroma and outcome
The number of patient deaths involving the interventri-
cular septum as the primary site of cardiac fibroma
(17/29, 58.6%) was significantly higher than that invol-
ving other sites (30/126, 23.8%) (c
2 test, P < 0.001). No
significant difference was found in DT/CW between
patients associate with interventricular septal involve-
ment of cardiac fibroma (n = 18, mean ± SD: 1.00 ±
0.78 mm/g) and other sites (n = 89, mean ± SD: 0.91 ±
0.79 mm/g) (Mann-Whitney U test, P = 0.917).
The number of patients showing arrhythmia with car-
diac fibroma involving the interventricular septum and
other sites was 16/29 (55.2%) and 40/126 (31.7%),
respectively. The former ratio is significantly higher than
the latter ratio (c
2 test, P = 0.018).
Discussion
To elucidate the significant poor prognostic factors asso-
ciated with the cardiac fibroma, we collected data in
accordance with PRISMA style as much as was possible.
Here, we wish to discuss the findings that emerged from
our survey and a specific case we encountered in relation
to cardiac fibroma.
In the present study, patients that did not survive were
significantly younger than those that did. This suggests
that a younger age at the time of diagnosis of cardiac
fibroma is associated with a poorer outcome. However,
no significant difference was found in the maximum dia-
meter of the tumor between both groups. Given that
younger individuals have a smaller heart than older indi-
viduals [17], the high ratio of tumor-to-heart size may
generate low cardiac output and therefore lead to a
poorer outcome. To confirm our hypothesis, we
appraised the tumor-to-heart size ratio of the patients by
dividing DT by the physiological CW [17]. The scatter
plot of DT/CW and the patient age at the time of diagno-
sis (Figure 1) showed a significant negative association
(Spearman’s rank correlation coefficient, r = -0.863, P <
0.001). Furthermore, a significant difference was found in
DT/CW between patients that survived (n = 62, mean ±
SD: 0.67 ± 0.57 mm/g) and those that did not survive
( n=2 0 ,m e a n±S D :1 . 1 6±0 . 7 5m m / g )( M a n n - W h i t n e y
U test: P = 0.008). These findings suggest that a high DT/
CW indicating largeness in relative size of tumor is a
poor prognostic factor for cardiac fibroma.
Our literature survey also revealed that 18 of 178
patients with cardiac fibroma (11.3%) were diagnosed
during the prenatal or neonatal period, and that this
tumor had a certain size regardless of the patient’sa g e .
These facts suggest that cardiac fibroma may be a con-
genital disorder. Additionally, we calculated the Spear-
man correlation coefficient to know the correlation
between the patient age and tumor diameter at the time
of diagnosis (n = 92, 85 not reported). The results
showed a significant positive association between them
(r = 0.338, P < 0.001), indicating that the tumor grew
with age. However, we described previously that no sig-
nificant difference was found in tumor diameter
between the (older) group that survived and the
(younger) group that did not survive. To better under-
standing the apparent paradoxical results of our statisti-
cal analyses, we suggested the hypothesis that this
tumor stops growing at a certain age. According to a
previous publication [16], the growth of the heart is
usually completed at 17 to 20 years of age. Therefore,
we calculated the Spearman correlation coefficient
between the patient age in patients under 17 years of
age (n = 64) and in patients over 17 years of age (n =
28) tumor diameter. The former group showed signifi-
cant positive correlation between the patient age and
tumor diameter (r = 0.341, P = 0.006), while the latter
group showed no significant correlation (r = -0.080, P =
0.676) between these factors. These results suggest that
the tumor grew with physiological cardiac growth.
The present study revealed that the left ventricle was
the most common site associated with cardiac fibroma
(98/171, 57.3%), consistent with previous reports [20,21],
followed by the right ventricle (47/171, 27.5%) and the
interventricular septum (29/171, 17.0%).
Figure 1 Scatter plot of diameter of the tumor/cardiac weight
(DT/CW) and the patient age at the time of diagnosis. DT/CW
was calculated by dividing the diameter of the tumor by the
physiological cardiac weight. Analysis of these factors using
Spearman’s rank correlation coefficient showed a significant
negative association (r = -0.863, P < 0.001).
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of the number of tumor sites (left ventricle: right ventri-
cle: interventricular septum, 98:47:29) and the cardiac
chamber weight (left ventricle free wall: right ventricle:
interventricular septum, 99:45:33) using the c
2 test. No
significant difference was found in ratio between the
number of tumor sites and the cardiac chamber weight
(P = 0.869). This finding indicated that the ratio of the
site where cardiac fibroma occurred corresponded with
the ratio of the muscular weight of the cardiac chamber.
The present study also shed some light on the correla-
tion between the site of cardiac fibroma and outcome.
The number of patient deaths involving the interventri-
cular septum as the primary site of cardiac fibroma (17/
29, 58.6%) was significantly higher in comparison to
deaths not involving the interventricular septum (30/
126, 23.8%) (c
2 test, P < 0.001). However, no significant
difference was found in DT/CW between patients asso-
ciated with interventricular septal involvement (n = 18,
mean ± SD: 1.00 ± 0.78 mm/g) and those associated
with other sites (n = 89, mean ± SD: 0.91 ± 0.79 mm/g)
(Mann-Whitney U test, P = 0.917). These results sug-
gested that septal involvement is a significant prognostic
factor for the tumor, regardless of the diameter relative
to heart size. To account for this phenomenon, the
tumor involving the interventricular septum may induce
malfunctioning in conduction system. We therefore
compared the prevalence of arrhythmia in patients with
the tumor involving between septum and other sites.
The group with septal involvement comprised 16 of 29
(55.2%) patients, while another group comprised 40 of
126 (31.7%) patients. The former ratio is significantly
higher than the latter’s( c
2 test, P =0 . 0 1 8 ) .H e n c et h e r e
i sat e n d e n c yf o rc a r d i a cf i b roma located at the inter-
ventricular septum to cause arrhythmias (Table 2).
Finally, we acknowledge that our study may be
affected by publication bias since it is based on a cumu-
lative case series.
Conclusions
Our literature survey reveals that younger age of the
patient at the time of diagnosis and septal involvement
can be regarded as significant poor prognostic factors for
cardiac fibroma, a tumor that grows with physiological
cardiac growth. Furthermore, our detailed statistical ana-
lyses support the following hypotheses. First, the high ratio
of tumor-to-heart size may generate low cardiac output
and therefore lead to a poorer prognosis. Second, the ratio
of the sites of cardiac fibroma occurrence corresponds
with the ratio of the muscular weight of the cardiac cham-
ber. Third, septal involvement is a significant poor prog-
nostic factor for cardiac fibroma regardless of tumor
diameter relative to heart size, since cardiac fibroma invol-
ving the interventricular septum more frequently induces
conduction system disease. However, further investigations
are required to confirm these hypotheses.
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